Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?

Kumar, Nitya; AbdulRahman, AbdulKarim; AlAwadhi, Abdulla Ismaeel; AlQahtani, Manaf

Kumar, Nitya; AbdulRahman, AbdulKarim; AlAwadhi, Abdulla Ismaeel; AlQahtani, Manaf.

Kumar N; Royal College of Surgeons in Ireland, Busaiteen, Bahrain. nkumar@rcsi-mub.com.
AbdulRahman A; Mohammed Bin Khalifa Cardiac Centre, Manama, Bahrain.
AlAwadhi AI; Bahrain Defense Force Hospital - Royal Medical Services, Riffa, Bahrain.
AlQahtani M; Royal College of Surgeons in Ireland, Busaiteen, Bahrain.

Sci Rep ; 11(1): 19213, 2021 09 28.

Article en En | MEDLINE | ID: mdl-34584152

Asunto(s)

COVID-19; Deficiencia de Glucosafosfato Deshidrogenasa/complicaciones; Enfermedad Aguda; Adulto; Factores de Edad; COVID-19/epidemiología; COVID-19/metabolismo; COVID-19/patología; Comorbilidad; Enfermedad Crítica; Femenino; Glucosa-6-Fosfatasa/metabolismo; Humanos; Masculino; Persona de Mediana Edad; SARS-CoV-2/patogenicidad

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Deficiencia de Glucosafosfato Deshidrogenasa Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google